Friday, December 5, 2025
Search: “Merck” | Glideslope AI

Search results for “Merck”

Clear
Chart will appear here.
Tip: pick a start and end date, then click Refine by Date. The chart and results update instantly (no reload).

Results

Explore Merck in Topics
marketwatch.com › post › 0zyzz4e

This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy

November 14, 2025
Merck is facing a patent cliff for Keytruda and upheaval in the market for Gardasil.
cnbc.com › post › t5wo3qs

Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics

November 14, 2025
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.
marketwatch.com › post › 7fosmdi

Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.

October 16, 2025
President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims to cut the out-of-pocket costs for in vitro fertilization, with the move coming more than a year after his campaign promise to eliminate…
nytimes.com › post › 91902391003889876481

FDA OKs New Keytruda Shot for Cancer

September 19, 2025
Merck says an injected version of its blockbuster infusion Keytruda is quicker and easier. But it stands to slow the adoption of cheaper competitors, increasing costs by billions of dollars.
nasdaq.com › post › 45594612968293492382

Dow Movers: WMT, MRK

August 21, 2025
In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the…
cnbc.com › post › 72616449273296820867

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

July 31, 2025
Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.
cnbc.com › post › 82080293116224221068

Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

July 29, 2025
The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster cancer drug Keytruda.
nasdaq.com › post › 44812360693642374310

Dow Movers: SHW, MRK

July 22, 2025
In early trading on Tuesday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.6%. Year to date, Merck has lost about 19.0% of its value. And the worst performing Dow component thus far on the …
nasdaq.com › post › 64550519671774504335

Does This Move Make Merck Stock a Buy?

July 20, 2025
Key PointsMerck is seeking ways to prepare for a significant upcoming patent cliff.
nasdaq.com › post › 41485232689095732497

See Which Of The Latest 13F Filers Holds MRK

July 13, 2025
At Holdings Channel, we have reviewed the latest batch of the 27 most recent 13F filings for the 06/30/2025 reporting period, and noticed that Merck & Co Inc (Symbol: MRK) was held by 18 of these funds. When hedge fund managers appear to be thinking alike…
marketwatch.com › post › 22193040324037900830

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma

July 9, 2025
Verona Pharma’s stock soars toward a record after $10 billion buyout deal with Merck.
abcnews.go.com › post › 19810253746659475067

Merck spends $10 billion for Verona, gaining access to its COPD medication

July 9, 2025
Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an approximately $10 billion deal
cnbc.com › post › 03146363766205218523

Merck shells out $10 billion for London-based lung therapy firm Verona

July 9, 2025
Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday.
cnbc.com › post › 12663979990145547903

RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants

June 26, 2025
The votes in favor of Merck's shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom are well-known vaccine critics. 
cnbc.com › post › 91347957424302240844

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan

June 17, 2025
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.
Showing 1-15 of 47

My Notes

Loading drafts...